Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Structural determinants of non-covalent PPARγ inverse agonism and their therapeutic implications.
Journal: Nature communications
Published: August 07, 2025
Structure-Activity Relationship and Biological Investigation of a REV-ERBα-Selective Agonist SR-29065 (34) for Autoimmune Disorders.
Journal: Journal of medicinal chemistry
Published: October 27, 2023
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents.
Journal: European journal of medicinal chemistry
Published: September 19, 2023
1,3-Diphenylureido hydroxamate as a promising scaffold for generation of potent antimalarial histone deacetylase inhibitors.
Journal: Scientific reports
Published: August 17, 2023
Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor.
Journal: Bioorganic & medicinal chemistry letters
Published: July 25, 2022
Morphing Natural Product Platensimycin via Heck, Sonogashira, and One-Pot Sonogashira/Cycloaddition Reactions to Produce Antibiotics with In Vivo Activity.
Journal: Antibiotics (Basel, Switzerland)
Published: February 21, 2022
Structure-based design of bitopic ligands for the µ-opioid receptor.
Journal: Nature
Published: February 14, 2022
Structure-Activity Relationship and Biological Investigation of SR18292 (16), a Suppressor of Glucagon-Induced Glucose Production.
Journal: Journal of medicinal chemistry
Published: January 12, 2021
Development of matrix metalloproteinase-13 inhibitors - A structure-activity/structure-property relationship study.
Journal: Bioorganic & medicinal chemistry
Published: May 29, 2018
Discovery of Hydrolysis-Resistant Isoindoline N-Acyl Amino Acid Analogues that Stimulate Mitochondrial Respiration.
Journal: Journal of medicinal chemistry
Published: March 14, 2018
Identification of an aminothiazole series of RORβ modulators.
Journal: Bioorganic & medicinal chemistry letters
Published: December 19, 2017
Development of dual casein kinase 1δ/1ε (CK1δ/ε) inhibitors for treatment of breast cancer.
Journal: Bioorganic & medicinal chemistry
Published: October 20, 2017
Last Updated: 09/26/2026